Tower Research Capital (TRC)’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Tower Research Capital (TRC)’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-13,131	Closed	-$1.26M	–	5500
2014 Q3	$1.14M	Buy	13,131 +3,875	+42%	+$343K	0.13%	147
2014 Q2	$835K	Buy	9,256 +8,439	+1,033%	+$631K	0.11%	126
2014 Q1	$60K	Buy	817 +421	+106%	+$29.4K	0.01%	974
2013 Q4	$27K	Sell	396 -7,376	-95%	-$480K	﹤0.01%	2021
2013 Q3	$474K	Buy	+7,772	New	+$474K	0.05%	341

Other funds holding COV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Tower Research Capital (TRC)'s COV Position: Q4 2014 in Review

Tower Research Capital (TRC) sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q4 2014, closing a stake of 13,131 shares — an estimated $1.26M sold.

Tower Research Capital (TRC) first reported a position in COV in Q3 2013 and held it in 5 quarters. The position peaked at $1.14M in Q3 2014. 758 funds tracked by Wall St. Rank hold COV as of Q4 2014.

Tower Research Capital (TRC) reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q4 2014 after selling out during the quarter.
Tower Research Capital (TRC) sold 13,131 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q4 2014, an estimated $1.26M.
Tower Research Capital (TRC) first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2013 and held it in 5 quarters.
Tower Research Capital (TRC)'s COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $1.14M in Q3 2014.
758 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q4 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2014, filed 5 Feb 2015.